|
A review of complaint activity determined that there was normal complaint activity for the likely cause lot 90357fn00.Tracking and trending report review for the architect cea assay determined that there were no trends identified.Since no patient sample was available for testing, a serum-based panel of samples, which mimics a patient sample, was performed using a retained kit of lot 90357fn00; all specifications were met, and the lot performed acceptably.Field data was reviewed and determined the patient median result for lot 90357fn00 is comparable with other lots in the field.Manufacturing documentation was reviewed and did not identify any issues.Additionally, labeling was reviewed and sufficiently addresses the customer issue.Based on the investigation, no systemic issue or deficiency of the architect cea assay was identified.
|